Protein Kinase Inhibitors: all 15,766 studies that test it
Page 139 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.
- Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01024205Phase 2
- A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product TestersCompletedNCT01023100Phase 1
- Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
- Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRICompletedNCT01020630Phase 2
- A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy VolunteersCompletedNCT01020136Phase 1
- Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerStatus unknownNCT01019798Phase 2
- Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaCompletedNCT01019434Phase 2
- An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)CompletedNCT01019161Phase 1
- Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in JapanCompletedNCT01018745Phase 1
- Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mgCompletedNCT01017679Phase 2
- OSI-906 and Irinotecan in Patients With Advanced CancerTerminatedNCT01016860Phase 1
- Study of NMS-1116354 in Solid TumorsTerminatedNCT01016327Phase 1
- Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01015664Phase 1/2
- Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
- Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid TumorsCompletedNCT01014429Phase 1
- Rapamycin and Regulatory T Cells in Kidney TransplantationCompletedNCT01014234Phase 2
- Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNCT01013831Phase 1
- Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWithdrawnNCT01013506Phase 2
- Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial CarcinomaCompletedNCT01013324Phase 2
- A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)WithdrawnNCT01011998Phase 2
- Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01011010Phase 1
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)CompletedNCT01010672Phase 2
- Everolimus on CKD Progression in ADPKD PatientsTerminatedNCT01009957Phase 2/3
- Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver CancerTerminatedNCT01009801Phase 1/2
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsCompletedNCT01009073Phase 1
- Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
- Erlotinib for Treatment of PsoriasisWithdrawnNCT01006096Phase 2
- ELBA: Exemestane and Lapatinib in Advanced Breast CancerWithdrawnNCT01005641Phase 2
- Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT01005472Phase 1
- Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver CancerCompletedNCT01005199Phase 2
- First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALLCompletedNCT01004497Phase 2
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWithdrawnNCT01004419Phase 1
- A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesCompletedNCT01004224Phase 1
- Autologous Transplantation for Chronic Myelogenous LeukemiaCompletedNCT01003054Phase 2
- Safety Study of BAY73-4506 in Patients With Hepatocellular CarcinomaCompletedNCT01003015Phase 2
- The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of RegorafenibCompletedNCT01002378Phase 1
- Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma PatientsTerminatedNCT01002248Phase 3
- Study Evaluating SKI-606 in Subject With Solid TumorsCompletedNCT01001936Phase 1
- Efficacy and Safety of Curcumin Formulation in Alzheimer's DiseaseTerminatedNCT01001637Not applicable
- Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWithdrawnNCT01000896Phase 1
- Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer PatientsCompletedNCT00999882Phase 1
- Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver CancerStatus unknownNCT00999843Phase 1/2
- A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid TumorsCompletedNCT00999401Phase 1
- Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant RecipientsStatus unknownNCT00999258Phase 4
- Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)CompletedNCT00998751Phase 2
- Study of Temsirolimus, Erlotinib and Cisplatin in Solid TumorsCompletedNCT00998036Phase 1
- Study of PKI-179 Administered Orally to Subjects With Solid TumorsWithdrawnNCT00997360Phase 1
- Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant PatientsCompletedNCT00997022Phase 1
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of LapatinibCompletedNCT00996762Phase 1
- Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)CompletedNCT00996723Phase 1
- Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy VolunteersCompletedNCT00996671Phase 1
- A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor MalignanciesCompletedNCT00996515Phase 1
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
- WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment ExaminationCompletedNCT00992563Phase 2
- Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00989690Phase 3
- Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationCompletedNCT00989469Phase 1/2
- Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNCT00988741Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)SuspendedNCT00986284Phase 2
- AT9283 in Children and Adolescents With Relapsed and Refractory Solid TumorsCompletedNCT00985868Phase 1
- A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid TumorsTerminatedNCT00985374Phase 1
- The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid TumorsCompletedNCT00984425Phase 1
- Treatment of Patients With Nephrogenic Systemic Fibrosis With GlivecCompletedNCT00981942Phase 3
- Stereotactic Radiosurgery With Sunitinib for Brain MetastasesCompletedNCT00981890Phase 1
- A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid MalignanciesCompletedNCT00981721Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic SyndromesCompletedNCT00981240Phase 1
- Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine HydrochlorideCompletedNCT00981162Phase 1
- Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus SunitinibCompletedNCT00979966Phase 2
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent GlioblastomaCompletedNCT00979862Phase 1
- Pharmacokinetics (PK) Study of AC480 for Recurrent GliomaCompletedNCT00979173Phase 1
- Evaluation of Response of Dasatinib to Treat MastocytosisStatus unknownNCT00979160Phase 2
- Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or LymphomaCompletedNCT00978523Phase 1
- Everolimus as First-Line Therapy in Treating Patients With Prostate CancerCompletedNCT00976755Phase 2
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
- Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's DiseaseCompletedNCT00976118Phase 2
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung CancerTerminatedNCT00975767Phase 1
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid TumorsCompletedNCT00975182Phase 1
- Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal SurgeryStatus unknownNCT00973869Phase 1
- Study of RAD001 in Advanced Cholangiocarcinoma: RADiCholStatus unknownNCT00973713Phase 2
- Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055CompletedNCT00973076Phase 1
- Dose-Escalation Study of GSK2126458CompletedNCT00972686Phase 1
- A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804TerminatedNCT00971191Phase 1
- Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
- Study of KRN951 in Patients With Solid TumorsCompletedNCT00970411Phase 1
- Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric CancerCompletedNCT00970138Phase 2/3
- A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT00969813Phase 1
- Trial of Curcumin in Cutaneous T-cell Lymphoma PatientsWithdrawnNCT00969085Phase 2
- Study in Neuropathic Pain Patients With Peripheral Nerve InjuryCompletedNCT00969059Phase 2
- Pharmacokinetics of Everolimus in Subjects With Hepatic InsufficiencyCompletedNCT00968591Phase 1
- Everolimus Dose Finding Study for Stage IV or Recurrent Cervical CancerWithdrawnNCT00967928Phase 1
- Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerCompletedNCT00967603Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus TherapyStatus unknownNCT00966836Phase 3
- Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCCompletedNCT00966472Phase 1
- Tamoxifen Citrate in Patients With Breast CancerStatus unknownNCT00963209Phase 3
- BAY80-6946 Open Label, Phase I Study in Patients With Advanced CancerCompletedNCT00962611Phase 1
- Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCompletedNCT00962507Phase 1